GNI Group Ltd.
GNI Group (2160) is a prominent player in the biotechnology and pharmaceutical sectors, primarily focused on the development and manufacturing of biopharmaceutical products. The company specializes in drug discovery, development, and production, offering a range of services that cater to the needs of global pharmaceutical companies. GNI Group is particularly known for its expertise in the production of active pharmaceutical ingredients (APIs) and its commitment to innovative solutions in biotechnology.